Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 17, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	218,644	297,962	170,528	81,683	-	-
Market Cap Growth	-31.08%	74.73%	108.77%	-	-	-
Enterprise Value	259,713	341,742	209,922	130,128	-	-
Last Close Price	164.66	224.60	128.72	66.76	-	-
PE Ratio	-	326.96	956.95	-	-	-
Forward PE	99.54	70.54	42.33	40.39	-	-
PS Ratio	2.46	3.26	2.09	1.15	-	-
PB Ratio	2.71	3.67	2.15	1.21	-	-
P/TBV Ratio	5.60	11.28	6.97	3.51	-	-
P/FCF Ratio	-	130.73	58.30	-	-	-
P/OCF Ratio	-	33.39	16.98	16.88	-	-
PEG Ratio	0.89	1.58	1.58	1.35	-	-
EV/Sales Ratio	2.93	3.73	2.57	1.84	-	-
EV/EBITDA Ratio	24.62	24.92	18.43	22.58	-	-
EV/EBIT Ratio	112.62	54.01	45.62	-	-	-
EV/FCF Ratio	-	149.94	71.77	-	-	-
Debt / Equity Ratio	0.60	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	4.87	3.44	4.00	9.21	3.63	2.30
Debt / FCF Ratio	-	21.31	16.10	-	-	-
Net Debt / Equity Ratio	0.51	0.55	0.53	0.74	0.57	0.47
Net Debt / EBITDA Ratio	4.30	3.24	3.68	8.70	3.47	2.03
Net Debt / FCF Ratio	-	19.52	14.34	-10.43	-31.27	-619.76
Asset Turnover	-	0.59	0.55	0.52	0.57	-
Inventory Turnover	-	1.58	1.69	1.94	1.87	-
Quick Ratio	-	0.75	0.61	0.64	0.69	0.82
Current Ratio	-	1.54	1.25	1.26	1.34	1.47
Return on Equity (ROE)	-	1.14%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	-	2.55%	1.93%	-0.20%	2.96%	-
Return on Invested Capital (ROIC)	-4.27%	1.13%	0.38%	-0.40%	4.62%	9.43%
Return on Capital Employed (ROCE)	-	5.30%	4.20%	-0.40%	5.70%	10.50%
Earnings Yield	-0.75%	0.31%	0.10%	-2.28%	-	-
FCF Yield	-	0.77%	1.71%	-5.89%	-	-
Dividend Yield	0.09%	0.06%	0.08%	-	-	-
Payout Ratio	-	15.88%	-	-	13.30%	-
Buyback Yield / Dilution	0.55%	-3.67%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	0.64%	-3.61%	-7.76%	-0.95%	-87.83%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.